The evidence relating oestrogen-progestogen oral contraceptives to venous thrombosis, pulmonary embolism, and cerebral thrombosis is reviewed. The risks associated with the use of oral contraceptives are then discussed in relation to the risks associated with the use of less effective methods of birth control.
SYNOPSIS
The evidence relating oestrogen-progestogen oral contraceptives to venous thrombosis, pulmonary embolism, and cerebral thrombosis is reviewed. The risks associated with the use of oral contraceptives are then discussed in relation to the risks associated with the use of less effective methods of birth control.
The possibility that the use of oral contraceptives might increase the risk of thromboembolic disease was first raised by a case report in the Lancet in 1961 (Jordan, 1961) . The patient concerned was a 40-year-old nurse who had been given Enavid for the control of endometriosis. After some weeks, the treatment had to be discontinued because of severe vomiting. Ten days later, that is, one week after the vomiting had stopped, the patient developed pulmonary embolism. Since that time many hundreds of similar case histories have been published in the medical journals or reported to national adverse drug reaction committees. The majority of these reports describe deep venous thrombosis of the lower limbs or pulmonary embolism, but others relate to cerebrovascular accidents, coronary thrombosis, mesenteric and other arterial thrombosis, and the Budd-Chiari syndrome.
All these disorders also occur in young women who do not use oral contraceptives and, in themselves, the case reports provide no valid evidence that the preparations are a cause of the diseases in question. For further progress, it is necessary to make estimates of the incidence of the diseases in women using oral contraceptives and to compare them with the incidence in women not doing so. This, of course, was appreciated at 'This paper is based in part on an article submitted for publication to the British Medical Bulletin.
once, and between 1962 and 1966 a number of such comparisons were made (Searle & Co., Chicago Conference, 1962; United States Food and Drug Administration 1963, 1966; Cahal, 1965) . Each of these comparisons, however, lacked satisfactory control data and depended on the voluntary notification of episodes of thromboembolism by doctors for the calculation of morbidity or mortality rates in users of oral contraceptives. These serious inadequacies inevitably led to inconclusive results and the problem remained unresolved until three controlled investigations were undertaken in the United Kingdom during 1966.
The three British studies were all of the retrospective or case-control type. In one, organized by the Royal College of General Practitioners (1967), 29 family doctors interviewed 147 married women aged 15-49 years who had consulted them for an episode of thromboembolic disease. In a second, Doll (1968, 1969) Retrospective studies are subject to many sources of bias and the results shown in Table I should not be accepted uncritically. In particular, they might have teen produced if doctors diagnosed thromboembolic disease more readily, or admitted patients to hospital more readily, when they obtained a history of the use of oral contraceptives than when they did not. Two pieces of evidence suggest that this type of bias is unlikely to explain the results. First, if diagnostic bias were a major factor, the association between the use of oral contraceptives and thrombeembolism should be strongest in those patients with the least objective evidence of the disease. In fact, the reverse was found to be true. In the investigation of Vessey and Doll, the proportion of patients who were using oral contraceptives rose from 380% of those with an uncertain diagnosis to 68 % of those in whom the diagnosis was established. Secondly, the number of admissions to hospital for venous thromboembolism among women using oral contraceptives increased progressively with the increase in the use of oral contraceptives in the general population, and no increase in the admission rate occurred after periods of maximum publicity concerning the thromboembolic hazards of the preparations.
At the time that the three British epidemiological investigations were being planned, a study very similar to the one carried out by Vessey and Doll was being developed, quite independently, in the United States. The findings in this investigation have now been reported (Sartwell, Masi, Arthes, Greene, and Smith, 1969) . One hundred and seventy-five women aged 15-44 discharged alive from 43 hospitals after initial attacks of 'idiopathic' thrombophlebitis, pulmonary embolism, or cerebral thrombosis or embolism, were identified, together with 175 carefully matched controls. All subjects were interviewed to provide information concerning their use of oral contraceptives before admission to hospital. From these data, it was estimated that the risk of admission to hospital for superficial thrombophlebitis was increased by the use of oral contraceptives 3.0 times, for deep vein thrombosis or pulmonary embolism 4 4 times, and for cerebral thrombosis 7.0 times. Considering the small numbers of subjects involved both in the British and in the American investigations, the degree of agreement between the findings in the various studies is remarkable.
In Isager and Pedersen (1966) . Only one series, that of Johnson and Rosen (1966) , has been reported as having a negative result. Close scrutiny of the data shows, however, that only six patients aged 15-39 were identified who had 'idiopathic' thromboembolism and of these one had had a hysterectomy. Of the remaining five, two had been using oral contraceptives. All these data must, of course, be interpreted with caution not only because of the absence of any control information but also because it is difficult to avoid the suspicion that negative series would have been less likely to be reported than positive ones.
2 Official mortality statistics for venous thromboembolism have been analysed for England and Wales by Vessey and Weatherall (1968) and for the United States by Markush and Seigel (1969) and Seigel and Markush (1969) . In both countries there has been a trend in the national death rates in young women compatible with the increase in the use of oral contraceptives and with the estimates of the risks associated with them.
3 Oestrogens, albeit in large doses, have been implicated as a factor in the causation of puerperal thromboembolism when they are used to suppress lactation (Daniel, Campbell, and Turnbull, 1967; Jeffcoate, Miller, Roos, and Tindall, 1968) . 4 Oestrogens have been shown to be a cause of thromboembolism, both arterial and venous, when they are administered to elderly men with arterial disease or cancer of the prostate (Schrogie and Solomon, 1967; Bailar, 1967) .
5 A large and confused literature has accumulated relating oral contraceptives to changes in circulating levels of various coagulation factors (see Drill, 1966, and Tausk, 1968 , for reviews). There is little doubt that some changes, notably increases in factors VII and X, are common, and although the significance of such changes is uncertain, they are at least consistent with the epidemiological findings. 6 Bolton, Hampton, and Mitchell (1968) have described an increase in platelet sensitivity to adenosine diphosphate as determined by the electrophoretic technique in subjects taking oral contraceptives, with a return of platelet behaviour to normal between treatment cycles. These changes in platelet behaviour are similar to those described by the same authors in patients with occlusive vascular disease. 7 Other workers (Danforth, Maralo-Estrella, and Buckingham, 1964; Goodrich and Wood, 1964; Neistadt, Schwartz, and Schwartz, 1966) have demonstrated changes in vessel walls and in venous distensibility and blood flow produced by the administration of oral contraceptives in man and in animals. Some of the evidence just described is also relevant to the occurrence of cerebral thrombosis, but in this connexion special mention must be made of several impressive but uncontrolled clinical series of ischaemic strokes in young women that have been reported in the literature. Heyman, Arons, Quinn, and Camplong (1969) , for example, studied all female patients aged 15-39 years seen at Duke University Hospital, North Carolina, from 1958-68, in whom a diagnosis of cerebral arterial occlusion without evident predisposing cause was made. In the intervals 1958-60, 1961-64, and 1965-68 , the numbers of patients seen who were not using oral contraceptives were four, four, and five respectively. The corresponding numbers who were using oral contraceptives were none, three, and seven respectively. Equally striking results have been published by Bickerstaff and Holmes (1967) and by Bergeron and Wood (1969) , while Illis, Kocen, McDonald, and Mondkar (1965) , Shafey and Scheinberg (1966) , and Cole (1967) have all reported comparable findings. Only Jennett and Cross (1967) have reported negative results. All these data must, however, be interpreted with caution, for the reasons that have been stated previously.
Type of Preparation and Duration of Use
None of the epidemiological data available at present indicate that the risk of thromboembolism is any greater early in the course of medication, when it might be expected to be concentrated if the effect was an idiosyncratic reaction in a specially susceptible fraction of the population, nor that it increases with increasing duration of use.
Extensive data are required to make adequate comparisons between the risks associated with different oral contraceptive formulations. Inman and Vessey (1968) and Vessey and Doll (1969) were unable to detect any such differences, but the results of the American study (Sartwell et al, 1969) suggest that sequential formulations are more hazardous than combined ones. From the public health point of view, however, it must be remembered that oestrogen-progestogen oral contraceptives, especially of the combined type, offer almost complete protection against pregnancy. All other methods are substantially less effective and in assessing the significance of the thromboembolic risks of oral contraception, due consideration must be given to the dangers of unwanted pregnancy.
For comparative purposes, adequate morbidity data are not available, but in regard to mortality, approximate calculations using widely accepted failure rates for alternative methods of birth control suggest that the thromboembolic hazards in women using oral contraceptives may be approximately balanced by the risks associated with unwanted pregnancies in women using the sheath or the diaphragm. The intrauterine device, on the other hand, shows itself in a favourable light in this type of calculation because it provides more effective contraception than the occlusive methods, but its apparent advantage may be offset by the dangers of uterine perforation and sepsis which have yet to be quantified (Scott, 1968) .
For the woman who, for any reason, finds oral contraception the only satisfactory method of birth control, the thromboembolic hazards should, therefore, prove acceptable. For the woman who is prepared to attend assiduously to an effective occlusive method, however, the decision may be less simple as it has been shown that among the highly motivated, failure rates well below those that are generally quoted may be obtained by such means (Sagi, Potter, and Westoff, 1962) . It should also be remembered that the use of oral contraceptives is known to entail risks other than the thrombeembolic ones (Doll and Vessey, 1970) and that our knowledge of the long-term effects of medication is still very incomplete.
Future Work
Each of the four controlled epidemiological studies has provided estimates of the risk of thromboembolism only for women who were previously in good health. It is, however, of considerable importance to know how the risk is affected in patients who have other predisposing conditions and, in particular, in those who have recently undergone surgery. This aspect of the problem may be satisfactorily evaluated by further case-control investigations.
There is also a need to confirm the results of the retrospective investigations by prospective studies of which at least three are now in progress (see Doll and Vessey, 1970) . Such studies, however, will be extremely difficult to carry out and will be subject to many of the sources of bias which could have affected the results of the casecontrol investigations. It is, in fact, quite possible that they will add little to our existing knowledge of the problem.
